Laurence Digue

3.1k total citations
57 papers, 927 citations indexed

About

Laurence Digue is a scholar working on Oncology, Surgery and Otorhinolaryngology. According to data from OpenAlex, Laurence Digue has authored 57 papers receiving a total of 927 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 19 papers in Surgery and 15 papers in Otorhinolaryngology. Recurrent topics in Laurence Digue's work include Salivary Gland Tumors Diagnosis and Treatment (16 papers), Head and Neck Cancer Studies (15 papers) and Ear and Head Tumors (9 papers). Laurence Digue is often cited by papers focused on Salivary Gland Tumors Diagnosis and Treatment (16 papers), Head and Neck Cancer Studies (15 papers) and Ear and Head Tumors (9 papers). Laurence Digue collaborates with scholars based in France, Austria and Belgium. Laurence Digue's co-authors include Florence Duffaud, R. Favre, Alain Botta, Michel Toubeau, B. Bridji, Vincent Grégoire, Max Lonneux, C. Duvillard, G. Calais and H Reychler and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Laurence Digue

56 papers receiving 908 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laurence Digue France 16 343 259 250 245 188 57 927
Raymond L. Chai United States 17 226 0.7× 325 1.3× 225 0.9× 376 1.5× 91 0.5× 67 875
Maria Cossu Rocca Italy 18 435 1.3× 237 0.9× 408 1.6× 299 1.2× 150 0.8× 70 949
Jin Gao China 19 418 1.2× 188 0.7× 158 0.6× 324 1.3× 147 0.8× 37 913
B.K. Mohanti India 15 252 0.7× 305 1.2× 320 1.3× 292 1.2× 197 1.0× 58 994
Marco Siano Switzerland 15 297 0.9× 93 0.4× 153 0.6× 105 0.4× 51 0.3× 43 639
Peiman Haddad Iran 14 254 0.7× 206 0.8× 247 1.0× 120 0.5× 39 0.2× 55 623
Hei Cheul Jeung South Korea 15 432 1.3× 433 1.7× 327 1.3× 44 0.2× 84 0.4× 32 941
Tao Jin China 18 288 0.8× 271 1.0× 289 1.2× 39 0.2× 83 0.4× 73 1.0k
Nuttapong Ngamphaiboon Thailand 17 515 1.5× 171 0.7× 223 0.9× 247 1.0× 124 0.7× 73 896
R J Black United Kingdom 8 319 0.9× 169 0.7× 203 0.8× 32 0.1× 90 0.5× 12 671

Countries citing papers authored by Laurence Digue

Since Specialization
Citations

This map shows the geographic impact of Laurence Digue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurence Digue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurence Digue more than expected).

Fields of papers citing papers by Laurence Digue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurence Digue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurence Digue. The network helps show where Laurence Digue may publish in the future.

Co-authorship network of co-authors of Laurence Digue

This figure shows the co-authorship network connecting the top 25 collaborators of Laurence Digue. A scholar is included among the top collaborators of Laurence Digue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurence Digue. Laurence Digue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dauzier, Etienne, Juliette Thariat, Nicolas Fakhry, et al.. (2024). Twelve years after: The french national network on rare head and neck tumours (REFCOR). Oral Oncology. 151. 106762–106762. 3 indexed citations
3.
Fayette, Jérôme, Caroline Even, Laurence Digue, et al.. (2023). NISCAHN: a phase II trial of nivolumab in patients with salivary gland carcinoma (Unicancer ORL-08). SHILAP Revista de lepidopterología. 2(1). e000065–e000065. 6 indexed citations
4.
Chabrillac, É., Caroline Even, Valérie Costes‐Martineau, et al.. (2023). Cancers rares de la tête et du cou sous l’égide du REFCOR, partie 1. Bulletin du Cancer. 110(6). 692–699. 1 indexed citations
5.
Chabrillac, É., Caroline Even, Valérie Costes‐Martineau, et al.. (2023). Cancers rares de la tête et du cou sous l’égide du REFCOR, partie 2. Bulletin du Cancer. 110(6). 700–706. 1 indexed citations
6.
Digue, Laurence, S. Vergèz, Juliette Thariat, et al.. (2023). Systemic therapies for salivary gland carcinoma (excluding adenoid cystic carcinoma): REFCOR recommendations by the formal consensus method. European Annals of Otorhinolaryngology Head and Neck Diseases. 141(5). 280–285. 5 indexed citations
7.
Thariat, Juliette, François‐Régis Ferrand, Nicolas Fakhry, et al.. (2023). Radiotherapy for salivary gland cancer: REFCOR recommendations by the formal consensus method. European Annals of Otorhinolaryngology Head and Neck Diseases. 141(4). 221–226. 10 indexed citations
8.
Ferrand, François‐Régis, Caroline Even, É. Chabrillac, et al.. (2023). Systemic therapies for salivary gland cancer: Adenoid cystic carcinoma. REFCOR recommendations by the formal consensus method. European Annals of Otorhinolaryngology Head and Neck Diseases. 141(5). 286–291. 6 indexed citations
9.
Fouchardière, Christelle de la, Yann Godbert, Cécile Dalban, et al.. (2021). Intermittent versus continuous administration of pazopanib in progressive radioiodine refractory thyroid carcinoma: Final results of the randomised, multicenter, open-label phase II trial PAZOTHYR. European Journal of Cancer. 157. 153–164. 11 indexed citations
10.
Thariat, Juliette, Benjamin Vérillaud, S. Vergèz, et al.. (2020). Diagnostic, pronostic et traitement des carcinomes nasosinusiens (hors mélanomes, sarcomes et lymphomes). Bulletin du Cancer. 107(5). 601–611. 7 indexed citations
11.
Alix‐Panabières, Catherine, Thierry Lafont, Ben Allal, et al.. (2019). Cetuximab pharmacokinetic/pharmacodynamics relationships in advanced head and neck carcinoma patients. British Journal of Clinical Pharmacology. 85(6). 1357–1366. 19 indexed citations
12.
Thariat, Juliette, Muriel Hourseau, Anne–Catherine Baglin, et al.. (2019). Variants des carcinomes épidermoïdes dans les voies aérodigestives supérieures (VADS), implications pour le diagnostic et la prise en charge, selon les référentiels du REFCOR. Bulletin du Cancer. 106(4). 395–403. 4 indexed citations
13.
Raynard, Bruno, Xavier Hébuterne, François Goldwasser, et al.. (2017). Représentations croisées sur l’alimentation et la dénutrition chez les patients atteints de cancer : résultats de l’étude NutriCancer2012. Bulletin du Cancer. 104(11). 921–928. 2 indexed citations
16.
Digue, Laurence, et al.. (2014). Critères de qualité en oncologie médicale pour la prise en charge des cancers de la tête et du cou. Bulletin du Cancer. 101(5). 486–495. 1 indexed citations
17.
Ravaud, Alain, Jean‐Christophe Bernhard, Marine Gross‐Goupil, Laurence Digue, & J. Ferrière. (2010). Inhibiteurs de mTOR : temsirolimus et évérolimus dans le traitement du cancer du rein. Bulletin du Cancer. 97(2). S45–S51. 12 indexed citations
18.
Salas, Sébastien, Karine Baumstarck, M. Alfonsi, et al.. (2009). Impact of the prophylactic gastrostomy for unresectable squamous cell head and neck carcinomas treated with radio-chemotherapy on quality of life: Prospective randomized trial. Radiotherapy and Oncology. 93(3). 503–509. 96 indexed citations
19.
Digue, Laurence, et al.. (2000). Osteosarcomas of flat bones in adolescents and adults. Cancer. 88(2). 324–332. 25 indexed citations
20.
Duffaud, Florence, et al.. (1998). Genotoxicity of doxorubicin and cisplatin : determination of a positive control for the micronucleus test. Annales de biologie clinique. 56(2). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026